Trial NCT00206089

View at ClinicalTrials.gov 
Org. Study IDs: D4003C00030

Last trial update was posted on 2010-11-15

MeSH Interventions

Melagatran Ximelagatran

MeSH Conditions

Thromboembolism

Other Conditions


Stopping Reasons

Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID